<DOC>
	<DOCNO>NCT00305552</DOCNO>
	<brief_summary>Sarcoidosis multisystem disease involve frequently lung , eye , lymph node skin . Skin lesion may disfigure impair quality life . Thalidomide multi-target drug show benefit skin sarcoidosis case report . The objective ass efficacy tolerance thalidomide skin sarcoidosis .</brief_summary>
	<brief_title>SARCOTHAL . Thalidomide Skin Sarcoidosis</brief_title>
	<detailed_description>The study consist compare thalidomide placebo skin sarcoidosis . Patients sarcoidosis necessitating high-dose corticosteroid regimen , assessable skin lesion , eligible . They randomize receive either thalidomide placebo 3 month . Then give Thalidomide 3-month open-label period .</detailed_description>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Biopsy proven skin sarcoidosis Assessable target skin lesion Rapidly evolve sarcoidosis Patients necessitate corticosteroid regimen 15mg per day . Women willing undertake contraceptive method . Neurologic impairment Past treatment Thalidomide Renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>Randomized control trial</keyword>
	<keyword>Thalidomide v placebo</keyword>
	<keyword>skin sarcoidosis</keyword>
	<keyword>Thalidomide</keyword>
</DOC>